News

Business

On HALO

3 hours ago

US shoulders disproportionate cost of new medications, report finds

New research by the Office of Health Policy shows the U.S. shoulders a disproportionate cost when it comes to paying for prescription medication.The report, obtained by FOX Business, shows Americans account for nearly 80% of the innovative revenue for drugs launched between 2020 and 2025. The report also shows that no other country comes close to the United States' contribution to shouldering the cost of research and development. The next-closest country paying the cost for R&D in that timeframe is Japan, which accounts for about 5.5% of innovative revenues for new medications coming onlin...